Decentralized Identifiers have recently expanded into Internet of Things devices and are crucial in securing users' digital identities and data. However, Decentralized Identifiers face challenges in scenarios necessitating authority delegation and anonymity, such as when dealing with legal guardianship for minors, device loss or damage, and specific medical contexts involving patient information. This paper aims to strengthen data sovereignty within the Decentralized Identifier system by implementing a secure authority delegation and anonymity scheme. It suggests optimizing verifiable presentations by utilizing a sequential aggregate signature, a Non-Interactive Zero-Knowledge Proof, and a Merkle tree to prevent against linkage and Sybil attacks while facilitating delegation. This strategy mitigates security risks related to delegation and anonymity, efficiently reduces the computational and verification efforts for signatures, and reduces the size of verifiable presentations by about 1.2 to 2 times.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11014293 | PMC |
| http://dx.doi.org/10.3390/s24072215 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Context: Anemia is a medical condition resulting from a reduction in the number of red blood cells below the reference range. It is a major public health problem, particularly among adolescents, as it can have negative effects on cognitive performance, growth and reproduction. This study aims to assess the determinants of anemia among adolescents in schools in the city of Douala.
View Article and Find Full Text PDFVariation between countries for routine transvaginal cervical length measurement and interventions to prevent preterm birth.
Eur J Obstet Gynecol Reprod Biol
December 2024
Amsterdam Reproduction & Development, Amsterdam, Netherlands (the); Amsterdam UMC Location University of Amsterdam, Department of Obstetrics and Gynaecology, Meibergdreef 9, Amsterdam, Netherlands (the).
Objective: To assess the variation between countries for routine transvaginal ultrasound assessment of the cervical length and interventions offered to prevent preterm birth (PTB).
Study Design: An anonymous digital questionnaire was sent out between August and October 2023 to delegates of the European Spontaneous Preterm Birth Congress. Outcomes assessed included method, indications (i.
Consensus Statements on Assessments and Vaccinations Prior to Commencement of Advanced Therapies for the Treatment of Inflammatory Bowel Diseases.
Aliment Pharmacol Ther
January 2025
Gastroenterology and Liver Services, Concord Repatriation General Hospital, Sydney, New South Wales, Australia.
Article Synopsis
- New advanced therapies for inflammatory bowel diseases (IBDs) require enhanced risk management strategies to ensure patient safety during treatment.
- A comprehensive set of eight statements was developed through literature review and expert consensus, focusing on assessments and vaccinations needed before starting therapies like JAK inhibitors and S1P modulators.
- Key findings include the necessity for infectious disease screenings, updated vaccination protocols, and specific risk assessments for malignancies and cardiovascular issues to reduce IBD complications associated with these advanced treatments.
Proceedings of the United Kingdom Periprosthetic Joint Infection Meeting 2022: Fracture-Related Infection Session.
Injury
November 2024
Department of Trauma and Orthopaedics, Queen Elizabeth University Hospital, Glasgow, United Kingdom.
Implant-related infections represent a relatively common and significant challenge in the surgical management of musculoskeletal trauma patients. The third United Kingdom Periprosthetic Joint Infection (UK PJI) Meeting convened in Glasgow on 1 April 2022, and brought together over 180 delegates, representing orthopaedics, infectious diseases, microbiology, plastic surgery, anaesthetics, and allied health professions, including pharmacy and specialist nurses. The meeting comprised a plenary session for all delegates, and separate breakout sessions for fracture-related infection (FRI) and arthroplasty.
View Article and Find Full Text PDFDemographic and Clinical Features of Visceral Leishmaniasis in Chad: A Prospective Cross-Sectional Survey.
Am J Trop Med Hyg
December 2024
Leishmaniasis Unit, International Center for Excellence in Research (ICER-Mali), Faculty of Medicine and Odonto-Stomatology, University of Science, Techniques and Technologies of Bamako, Bamako, Mali.
Article Synopsis
- Visceral leishmaniasis (VL), caused by the Leishmania donovani complex, is becoming increasingly documented in Chad, particularly in the Léré district, indicating it may be endemic in the region.
- In a study involving 40 patients, 82.5% tested positive for VL through blood tests, with the most affected age groups being 15-29 and 0-14 years, and common symptoms including fever and weight loss.
- The study highlighted the need for better health education and training for healthcare workers in Chad to enhance early detection and management of VL, as 35% of cases required treatment and there were reported fatalities associated with comorbid conditions.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!